NYSEAMERICAN:YCBDcbdMD Stock Price, Forecast & News

$0.79

-0.08 (-9.66 %)

(As of 04/7/2020 03:45 PM ET)

Add

Compare

Today's Range

$0.79

Now: $0.79▼

$0.93

50-Day Range N/A

52-Week Range

$0.50

Now: $0.79▼

$7.24

Volume7,007 shs

Average Volume900,971 shs

Market Capitalization$40.31 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

cbdMD, Inc. produces and distributes various cannibidiol (CBD) products in the United States. It operates through three segments: Products, Licensing, and Entertainment. The Products segment produces and markets CBD tinctures, capsules, gummies, bath bombs, vape oils, topical creams, and animal treats and oils under the cdbMD brand. The Licensing segment establishes brands through licensing of select products/categories focusing on health and wellness, and men's lifestyle products. The Entertainment segment produces and markets various entertainment distribution platforms under the EE1 brand. This segment offers recordings, film, TV, Web and live events, and entertainment experiences; and brand management services, including creative development and marketing, brand strategy, and distribution support. cbdMD, Inc. also provides hair care products, including shampoos, conditioners, styling aides, and a patented styling tool through retailers and online outlets. The company was formerly known as Level Brands, Inc. and changed its name to cbdMD, Inc. in May 2019. cbdMD, Inc. was founded in 2015 and is based in Charlotte, North Carolina.

Beat the Market (BTM) Rank^™

3.0 Analyst's Opinion

Consensus Rating
cbdMD has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 2 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $5.20, cbdMD has a potential upside of 562.3% from its current price of $0.79.
Amount of Analyst Coverage
cbdMD has only been the subject of 1 research reports in the past 90 days.

2.3 Community Rank

Outperform Votes
cbdMD has received 23 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
cbdMD has received 28 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
cbdMD has received 54.90% “underperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about cbdMD and other stocks. Vote “Outperform” if you believe YCBD will outperform the S&P 500 over the long term. Vote “Underperform” if you believe YCBD will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
cbdMD does not currently pay a dividend.
Dividend Growth
cbdMD does not have a long track record of dividend growth.

3.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, cbdMD insiders have bought more of their company's stock than they have sold. Specifically, they have bought $182,250.00 in company stock and sold $0.00 in company stock.

0.0 Earnings and Valuation

Overall Beat the Market Rank^™

1.66 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN

Industry Marketing Services

Sub-IndustryN/A

SectorConsumer Cyclical

Current SymbolNYSEAMERICAN:YCBD

Previous Symbol

CUSIPN/A

CIKN/A

Webhttp://www.cbdmd.com/

Phone704-445-5800

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Employees50

Outstanding Shares51,336,000

Market Cap$40.31 million

Next Earnings Date5/20/2020 (Estimated)

OptionableNot Optionable

Receive YCBD News and Ratings via Email

Sign-up to receive the latest news and ratings for YCBD and its competitors with MarketBeat's FREE daily newsletter.

cbdMD (NYSEAMERICAN:YCBD) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of cbdMD?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for cbdMD in the last year. There are currently 2 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for cbdMD.

When is cbdMD's next earnings date?

cbdMD is scheduled to release its next quarterly earnings announcement on Wednesday, May 20th 2020. View our earnings forecast for cbdMD.

How were cbdMD's earnings last quarter?

cbdMD, Inc. (NYSEAMERICAN:YCBD) issued its quarterly earnings results on Thursday, February, 13th. The company reported $0.45 EPS for the quarter, beating the Zacks' consensus estimate of ($0.15) by $0.61. The business had revenue of $10.41 million for the quarter. View cbdMD's earnings history.

What guidance has cbdMD issued on next quarter's earnings?

cbdMD updated its second quarter 2020 Pre-Market earnings guidance on Monday, April, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $9.4-9.4 million, compared to the consensus revenue estimate of $11.33 million.

What price target have analysts set for YCBD?

2 analysts have issued 12 month price objectives for cbdMD's shares. Their forecasts range from $3.40 to $7.00. On average, they expect cbdMD's stock price to reach $5.20 in the next year. This suggests a possible upside of 562.3% from the stock's current price. View analysts' price targets for cbdMD.

Has cbdMD been receiving favorable news coverage?

Media coverage about YCBD stock has trended very negative on Tuesday, InfoTrie reports. InfoTrie rates the sentiment of media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. cbdMD earned a media sentiment score of -3.3 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the stock's share price in the near term. View the latest news aboutcbdMD.

Who are some of cbdMD's key competitors?

Some companies that are related to cbdMD include Cello Health (CLL), GTN (GTN), Trimantium Growthops (TGO), I Synergy Group (IS3), IVE Group (IGL), Ebiquity (EBQ), NAHL Group (NAH), Tech Mpire (TMP), Arena Events Group (ARE), System1 Group (SYS1), Engage:BDR (EN1), Inuvo (INUV), Inuvo (INUV), BlueRush (BTV) and Grand Vision Media (GVMH).

What other stocks do shareholders of cbdMD own?

Based on aggregate information from My MarketBeat watchlists, some companies that other cbdMD investors own include Corbus Pharmaceuticals (CRBP), QUALCOMM (QCOM), AbbVie (ABBV), Pfizer (PFE), Cara Therapeutics (CARA), GW Pharmaceuticals PLC- (GWPH), Pattern Energy Group (PEGI), Zynerba Pharmaceuticals (ZYNE), Canopy Growth (CGC) and Energy Transfer LP Unit (ET).

What is cbdMD's stock symbol?

cbdMD trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "YCBD."

How do I buy shares of cbdMD?

Shares of YCBD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is cbdMD's stock price today?

One share of YCBD stock can currently be purchased for approximately $0.79.

How big of a company is cbdMD?

cbdMD has a market capitalization of $40.31 million. cbdMD employs 50 workers across the globe. View additional information about cbdMD.

What is cbdMD's official website?

The official website for cbdMD is http://www.cbdmd.com/.

How can I contact cbdMD?

The company can be reached via phone at 704-445-5800.

This page was last updated on 4/7/2020 by MarketBeat.com Staff

Featured Article: Initial Coin Offering (ICO)